Biotech

All Articles

8 months after a $213M fundraise, gene editor Tome helps make decreases

.After raising $213 thousand in 2023-- some of the year's largest private biotech rounds-- Volume Bi...

BioMarin creates director team with biotech vets-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of notable management hirings, shootings as well...

Biopharma Q2 VC hit highest degree since '22, while M&ampA reduced

.Venture capital financing in to biopharma cheered $9.2 billion around 215 handle the 2nd fourth of ...

Bicara, Zenas seek IPOs to press late-phase possessions towards market

.Bicara Rehabs and Zenas Biopharma have actually delivered clean catalyst to the IPO market along wi...

Genentech to close cancer cells immunology analysis division

.Genentech will certainly shut its cancer immunology analysis team, and system mind and prominent ti...

Kezar falls solid lump yet to prove its own worth in period 1 test

.Kezar Lifestyle Sciences is falling its own dim phase 1 solid tumor medication as the biotech goes ...

Acelyrin falls izokibep, lets go 3rd of personnel

.Despite izokibep sustaining its newly found winning streak in the clinic, Acelyrin is actually no m...

Rivus' stage 2 obesity-related heart failure trial attacks endpoint

.Rivus Pharmaceuticals has plumped up the prospects of its fat-busting, muscle-sparing medication pr...

Ovid stops preclinical work, IV program after soticlestat neglect

.Ovid Therapeutics actually exposed final month that it was trimming back its own headcount as the b...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Seaport

.Eli Lilly has opened a $700 thousand R&ampD center in the Boston Seaport, improving its RNA as well...